Robert Hutnik

Robert Hutnik

Auto-generated profile, based on publicly available information

Robert Hutnik

Department of Anesthesiology, University of Florida, Gainesville, FL, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2022 in Interventional Neuroradiology
Verified
Journal Article
Closed access
ZRZubir S. Rentiya
Zubir S. Rentiya
AKAnna Luisa Kuhn
Anna Luisa Kuhn
RHRobert Hutnik
Robert Hutnik
MSMohammed Salman Shazeeb
Mohammed Salman Shazeeb
RLReade De Leacy
Reade De Leacy
APAjit S. Puri
Ajit S. Puri
Purpose: Transradial access (TRA) for diagnostic and interventional neurointerventional procedures has recently gained traction over transfemoral access (TFA) in the neurointerventional community. This meta-analysis aims to assess and summarize the utility of TRA in cerebral angiography and neurointerventional procedures. Methods: A systematic literature review was performed utilizing Pubmed, Embase, and Scopus databases. Using PRISMA guidelines, records were extracted with the following search terms: transradial approach, transradial access, radial access, cerebral angiogram, cerebral angiography, neurointervention, and neuroendovascular. The primary outcomes assessed were case success rate, complication rate, and crossover rate from TRA to TFA. Secondary analysis was performed on procedure time, fluoroscopy time, fluoroscopy time per vessel (diagnostic procedures only), contrast dose, radial artery diameter, distal radial artery diameter, and patient preference for TRA over TFA. Results: Sixty-two full-text articles were analyzed for this meta-analysis, representing 12,927 diagnostic and interventional TRA access patients. Our analysis revealed a combined diagnostic and interventional case success rate of 95.9% and complication rate of 3.5%, with crossover to TFA occurring in 4.9% of cases. Conclusion: This meta-analysis demonstrates that TRA access for diagnostic angiography and neurointerventional procedures is a safe and effective approach, though determining a true complication rate is challenging as the definition of TRA complications has changed in various publications over time.

3 March 2020 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
ZRZubir Rentiya
Zubir Rentiya
RHRobert Hutnik
Robert Hutnik
YMYolunna Q Mekkam
Yolunna Q Mekkam
JBJunun Bae
Junun Bae

9 May 2019 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
ATAlisa Timashpolsky
Alisa Timashpolsky
RHRobert Hutnik
Robert Hutnik
MMMelissa M. Mortensen
Melissa M. Mortensen

15 April 2020 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
RHRobert Hutnik
Robert Hutnik
PCPhilip G. Chen
Philip G. Chen
MMMelissa M. Mortensen
Melissa M. Mortensen
Obstructive sleep apnea (OSA) is commonly encountered in the pediatric population and has a large differential diagnosis. As clinicians, we must determine who needs to undergo flexible laryngoscopy...

1 January 2022 in Arquivos Brasileiros de Oftalmologia
Verified
Journal Article
Open access
ZRZubir S. Rentiya
Zubir S. Rentiya
DFDaniel A. Ferraz
Daniel A. Ferraz
RHRobert Hutnik
Robert Hutnik
JBJunun Bae
Junun Bae
CMCleide G. Machado
Cleide G. Machado
WTWalter Y. Takahashi
Walter Y. Takahashi
Purpose: To evaluate contrast sensitivity in non-high-risk, treatment-naïve proliferative diabetic retinopathy patients treated with panretinal photocoagulation and intravitreal injections of ranibizumab) versus panretinal photocoagulation alone. Methods: Sixty eyes of 30 patients with bilateral proliferative diabetic retinopathy were randomized into two groups: one received panretinal photocoagulation and ranibizumab injections (study group), while the other received panretinal photocoagulation alone (control group). All eyes were treated with panretinal photocoagulation in three sessions according to the Early Treatment Diabetic Retinopathy Study guidelines. Contrast sensitivity measurements were performed under photopic conditions (85 cd/m2) with the Visual Contrast Test Sensitivity 6500 chart, allowing for the evaluation of five spatial frequencies with sine wave grating charts: 1.5, 3.0, 6.0, 12.0, and 18.0 cycles per degree (cpd). Outcomes were measured in contrast sensitivity threshold scores among and within groups, from baseline to 1, 3, and 6 months. Results: Fifty-eight eyes (28 in the study group and 30 in the control group) reached the study endpoint. A comparative analysis of changes in contrast sensitivity between the groups showed significant differences mainly in low frequencies as follows: at month 1 in 1.5 cpd (p=0.001) and 3.0 cpd (p=0.04); at month 3 in 1.5 cpd (p=0.016), and at month 6 in 1.5 cpd (p=0.001) and 3.0 cpd (p=0.026) in favor of the study group. Conclusions: In eyes of patients with non-high-risk proliferative diabetic retinopathy, panretinal photocoagulation treatment with ranibizumab appears to cause less damage to contrast sensitivity compared with panretinal photocoagulation treatment alone. Thus, our evaluation of contrast sensitivity may support the use of ranabizumab as an adjuvant to panretinal photocoagulation for the treatment of proliferative diabetic retinopathy.